← Leaderboards
Yong Zhang
University Of Southern California
$5,658,789
Attributed
$5,658,789
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,658,789 · 3
By mechanism
R01$3,612,417 · 2
R35$2,046,372 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Thomas Susko$347,081
- Yingxiao Wang$19,926,530
- Chaim O. Jacob$10,639,828
- Sun Young Lee$2,032,954
- Albert Ernesto Almada$1,621,973
Others in their field
Other Emerging Leaders on “Innovation”
- Klaus Romero · Critical Path Institute$86,053,372
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$70,992,558
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$69,953,681
- Tony Moody · Duke University$65,625,959
- Matthew Johnson · Duke University$60,590,296
Research focus
InnovationPathway InteractionsBiologyMediatingProteinsCell PhysiologyTechnologyPlayPhysiologicalFunctional DisorderPathogenesisHuman DiseasePhysiologyBiological ProcessNew Therapeutic TargetLeadNicotinamide Adenine DinucleotideAreaAdenosine Diphosphate RiboseEventChemistryComplexAdp RibosylationAdp Ribose Transferases
Grant awards (15)
Reprogramming Exosomes for Novel Immunotherapy of Triple Negative Breast Cancer$513,250
R01 · FY2025 · CA · contact PI
Reprogramming Exosomes for Biomedical Applications$517,023
R01 · FY2024 · EB · contact PI
Reprogramming Exosomes for Novel Immunotherapy of Triple Negative Breast Cancer$487,588
R01 · FY2024 · CA · contact PI
Chemistry and Biology of ADP-Ribosylation-Dependent Signaling$378,183
R35 · FY2024 · GM · contact PI
Reprogramming Exosomes for Biomedical Applications$527,574
R01 · FY2023 · EB · contact PI
Reprogramming Exosomes for Novel Immunotherapy of Triple Negative Breast Cancer$511,834
R01 · FY2023 · CA · contact PI
Chemistry and Biology of ADP-Ribosylation-Dependent Signaling$378,183
R35 · FY2023 · GM · contact PI
Chemistry and Biology of ADP-Ribosylation-Dependent Signaling$11,601
R35 · FY2023 · GM · contact PI
Reprogramming Exosomes for Biomedical Applications$527,574
R01 · FY2022 · EB · contact PI
Chemistry and Biology of ADP-Ribosylation-Dependent Signaling$378,183
R35 · FY2022 · GM · contact PI
Chemistry and Biology of ADP-Ribosylation-Dependent Signaling$69,604
R35 · FY2022 · GM · contact PI
Reprogramming Exosomes for Biomedical Applications$527,574
R01 · FY2021 · EB · contact PI
Chemistry and Biology of ADP-Ribosylation-Dependent Signaling$378,183
R35 · FY2021 · GM · contact PI
Chemistry and Biology of ADP-Ribosylation-Dependent Signaling$58,002
R35 · FY2021 · GM · contact PI
Chemistry and Biology of ADP-Ribosylation-Dependent Signaling$394,433
R35 · FY2020 · GM · contact PI